Prolyl 4‐hydroxylase subunit alpha 1 (P4HA1) is a biomarker of poor prognosis in primary melanomas, and its depletion inhibits melanoma cell invasion and disrupts tumor blood vessel walls
Journal article published in 2020 by
Johanna Eriksson,
Vadim Le Joncour 
,
Tiina Jahkola,
Susanna Juteau,
Pirjo Laakkonen ,
Olli Saksela,
Erkki Hölttä
,
Tiina Jahkola,
Susanna Juteau,
Pirjo Laakkonen ,
Olli Saksela,
Erkki Hölttä
This paper is made freely available by the publisher.
Full text: Download
Data provided by 